---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-001419"
form_type: "8-K"
ticker: "VXRT"
cik: "0000072444"
company_name: "Vaxart, Inc."
filed_at: "2024-01-16T23:59:59+00:00"
generated_at: "2026-06-06T23:36:22.416931+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Vaxart raises $10M via registered direct offering of 15.4M shares at $0.65/share

## Summary
- Sold 15,384,615 shares to RA Capital Management at $0.65 per share for gross proceeds of $10.0M.
- Proceeds to be used for general corporate purposes including working capital and operating expenses.
- Offering is expected to close on or about January 18, 2024, subject to customary conditions.
- Shares are offered under an existing shelf registration statement on Form S-3.

## SEC filing metadata
- accession: 0001437749-24-001419
- form_type: 8-K
- ticker: VXRT
- cik: 0000072444
- company_name: Vaxart, Inc.
- filed_at: 2024-01-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/72444/000143774924001419/0001437749-24-001419-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/72444/000143774924001419/vxrt20240116_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-001419
- JSON: https://secwatch.observer/filing/0001437749-24-001419.json
- Plain text: https://secwatch.observer/filing/0001437749-24-001419.txt

## Key facts
- Material Agreements
  Vaxart, Inc. entered into Securities Purchase Agreement with RA Capital Healthcare Fund, L.P valued at approximately $10 million (effective 2024-01-16).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: RA Capital Healthcare Fund, L.P
  - Value: approximately $10 million
  - Effective: 2024-01-16
  source text: On January 16, 2024, Vaxart, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with RA Capital Healthcare Fund, L.P (“RA Capital”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/72444/000143774924001419/0001437749-24-001419-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.